-
Medical Economics Named National and Regional Winner of 2020 Azbee Awards of Excellence
Post on 6/24/20
-
AsclepiX Therapeutics Raises $35M Series A
Post on 6/24/20
-
IVERIC bio Announces Closing of Public Offering
Post on 6/23/20
-
Stellar Health and Accurate Diagnostic Laboratories Announce Strategic Collaboration
Post on 6/23/20
-
TARA Biosystems Announces $10 Million Series A2 Financing
Post on 6/23/20
-
Outlook Therapeutics Announces $11.2 Million Financings
Post on 6/23/20
-
States that Have the Fewest Coronavirus Restrictions – Updated WalletHub Study
Post on 6/23/20
-
Better Buy: Verizon Communications vs. Johnson & Johnson
Post on 6/23/20
-
Novartis Shuts Down Hydroxychloroquine COVID-19 Clinical Trial
Post on 6/23/20
-
Provention Bio Closes Public Offering of Common Stock
Post on 6/22/20
-
Regeneron Announces the 2020 Winners of the Regeneron Prize for Creative Innovation
Post on 6/22/20
-
Athenex Announces $225 Million Loan Agreement with Oaktree
Post on 6/22/20
-
Evergreen Theragnostics Completes $19 Million Series A
Post on 6/22/20
-
Better Buy: Novartis vs. Teva Pharmaceutical
Post on 6/22/20
-
Celldex Therapeutics Prices $130.4M Public Offering of Common Stock
Post on 6/21/20
-
Royalty Pharma Prices IPO
Post on 6/21/20
-
Celldex Therapeutics Proposes Public Offering of Common Stock
Post on 6/21/20
-
Agios and Royalty Pharma Announce $255M Purchase Agreement for IDHIFA Royalty
Post on 6/21/20
-
Actinium Pharmaceuticals Closes $25M Public Offering
Post on 6/21/20
-
Better Buy: Pfizer vs. Merck
Post on 6/19/20
-
Pfizer and Sangamo's Gene Therapy Continues to Help Patients with Hemophilia in Clinical Trial
Post on 6/19/20
-
Better Buy: Intercept Pharmaceuticals vs. Madrigal Pharmaceuticals
Post on 6/19/20
-
KORU Medical Commences Public Offering of Common Stock
Post on 6/18/20
-
Provention Bio Announces Pricing of $95.7 Million Public Offering of Common Stock
Post on 6/18/20
-
IVERIC bio Announces Pricing of Upsized Public Offering of Common Stock
Post on 6/18/20
New York
